MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart

Journal of Cardiovascular Pharmacology

Volumn 65, Issue 3, 2015, Pages 241-251

  Dakhlallah, Duaa ^a,b   Zhang, Jianying ^c   Yu, Lianbo ^c   Marsh, Clay B ^a   Angelos, Mark G ^a   Khan, Mahmood ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b Department of Engineering American University of the Safat   (Kuwait)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

mesenchymal stem cells; micro RNAs; myocardial infarction

Indexed keywords

ANTAGOMIR; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE 3; CASPASE 9; MICRORNA; MICRORNA 133; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; MIRN133 MICRORNA, RAT; OLIGONUCLEOTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ENGINEERING; CELL SURVIVAL; CELL VIABILITY; CELL VIABILITY ASSAY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HEART FUNCTION; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MTT ASSAY; NONHUMAN; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; STEM CELL GENE THERAPY; ANIMAL; APOPTOSIS; CARDIAC MUSCLE; CELL CULTURE; CONVALESCENCE; DISEASE MODEL; FIBROSIS; FISCHER 344 RAT; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; GRAFT SURVIVAL; HEART STROKE VOLUME; MESENCHYMAL STROMA CELL; METABOLISM; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; REGENERATION; TIME FACTOR; TISSUE ENGINEERING;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FIBROSIS; GENE EXPRESSION REGULATION; GRAFT SURVIVAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICRORNAS; MYOCARDIAL INFARCTION; MYOCARDIUM; OLIGONUCLEOTIDES; RATS, INBRED F344; RECOVERY OF FUNCTION; REGENERATION; STROKE VOLUME; TIME FACTORS; TISSUE ENGINEERING; TRANSFECTION;

EID: 84925484043     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000183     Document Type: Article

References (48)

1. Heron M. Deaths: leading causes for 2007. Natl Vital Stat Rep. 2011;59: 1-95.
2. Go AS, Mozaffarian D, Roger VL, et al; American Heart Association Statistics Committee, Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2014 update: a report from the American Heart Association. Circulation. 2014;129:e28-e292.
3. Agbulut O, Vandervelde S, Al Attar N, et al. Comparison of human skeletal myoblasts and bone marrow-derived CD133+ progenitors for the repair of infarcted myocardium. J Am Coll Cardiol. 2004;44: 458-463.
4. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7:430-436.
5. Orlic D, Kajstura J, Chimenti S, et al. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann N Y Acad Sci. 2001;938: 221-229; discussion 9-30.
6. Pagani FD, DerSimonian H, Zawadzka A, et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol. 2003;41:879-888.
7. Tse HF, Kwong YL, Chan JK, et al. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet. 2003;361:47-49.
8. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41-49.
9. Toma C, Pittenger MF, Cahill KS, et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002;105:93-98.
10. Shake JG, Gruber PJ, Baumgartner WA, et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects. Ann Thorac Surg. 2002;73:1919-1925; discussion 26.
11. Al-Khaldi A, Al-Sabti H, Galipeau J, et al. Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model. Ann Thorac Surg. 2003;75:204-209.
12. Beltrami AP, Barlucchi L, Torella D, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114:763-776.
13. Kuramochi Y, Fukazawa R, Migita M, et al. Cardiomyocyte regeneration from circulating bone marrow cells in mice. Pediatr Res. 2003;54: 319-325.
14. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-705.
15. Lagos-Quintana M, Rauhut R, Yalcin A, et al. Identification of tissuespecific microRNAs from mouse. Curr Biol. 2002;12:735-739.
16. Aghabozorg Afjeh SS, Ghaderian SM. The role of microRNAs in cardiovascular disease. Int J Mol Cell Med. 2013;2:50-57.
17. Garofalo M, Condorelli G, Croce CM. MicroRNAs in diseases and drug response. Curr Opin Pharmacol. 2008;8:661-667.
18. Meder B, Katus HA, Rottbauer W. Right into the heart of microRNA-133a. Genes Dev. 2008;22:3227-3231.
19. Bostjancic E, Zidar N, Stajer D, et al. MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology. 2010;115:163-169.
20. Ye Y, Perez-Polo JR, Qian J, et al. The role of microRNA in modulating myocardial ischemia-reperfusion injury. Physiol Genomics. 2011;43: 534-542.
21. Tatsuguchi M, Seok HY, Callis TE, et al. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol. 2007;42:1137-1141.
22. Villar AV, Merino D, Wenner M, et al. Myocardial gene expression of microRNA-133a and myosin heavy and light chains, in conjunction with clinical parameters, predict regression of left ventricular hypertrophy after valve replacement in patients with aortic stenosis. Heart. 2011;97: 1132-1137.
23. Sayed D, Hong C, Chen IY, et al. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res. 2007;100: 416-424.
24. Liu N, Bezprozvannaya S, Williams AH, et al. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev. 2008;22:3242-3254.
25. Care A, Catalucci D, Felicetti F, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med. 2007;13:613-618.
26. Matkovich SJ, Wang W, Tu Y, et al. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res. 2010;106:166-175.
27. Duisters RF, Tijsen AJ, Schroen B, et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res. 2009;104:170-178, 6p following 178.
28. Khan M, Meduru S, Gogna R, et al. Oxygen cycling in conjunction with stem cell transplantation induces NOS3 expression leading to attenuation of fibrosis and improved cardiac function. Cardiovasc Res. 2012; 93:89-99.
29. Hassan F, Meduru S, Taguchi K, et al. Carvedilol enhances mesenchymal stem cell therapy for myocardial infarction via inhibition of caspase-3 expression. J Pharmacol Exp Ther. 2012;343:62-71.
30. Dakhlallah D, Batte K, Wang Y, et al. Epigenetic regulation of miR-17;92 contributes to the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med. 2013;187:397-405.
31. Wisel S, Khan M, Kuppusamy ML, et al. Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression. J Pharmacol Exp Ther. 2009;329:543-550.
32. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article3.
33. Hunter MP, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One. 2008;3:e3694.
34. Ikeda S, Kong SW, Lu J, et al. Altered microRNA expression in human heart disease. Physiol Genomics. 2007;31:367-373.
35. Sucharov C, Bristow MR, Port JD. miRNA expression in the failing human heart: functional correlates. J Mol Cell Cardiol. 2008;45: 185-192.
36. Kim GH, Samant SA, Earley JU, et al. Translational control of FOG-2 expression in cardiomyocytes by microRNA-130a. PLoS One. 2009;4: e6161.
37. Wang S, Aurora AB, Johnson BA, et al. The endothelial-specific micro-RNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008;15:261-271.
38. Wang K, Long B, Zhou J, et al. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy. J Biol Chem. 2010;285:11903-11912.
39. He B, Xiao J, Ren AJ, et al. Role of miR-1 and miR-133a in myocardial ischemic postconditioning. J Biomed Sci. 2011;18:22.
40. Hu S, Huang M, Nguyen PK, et al. Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation. Circulation. 2011;124(11 suppl l):S27-S34.
41. Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell. 1997;91:443-446.
42. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science. 2004;305:626-629.
43. Luo X, Budihardjo I, Zou H, et al. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 1998;94:481-490.
44. Reubold TF, Wohlgemuth S, Eschenburg S. Crystal structure of fulllength Apaf-1: how the death signal is relayed in the mitochondrial pathway of apoptosis. Structure. 2011;19:1074-1083.
45. Yuan S, Akey CW. Apoptosome structure, assembly, and procaspase activation. Structure. 2013;21:501-515.
46. Hu Y, Benedict MA, Ding L, et al. Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. EMBO J. 1999;18:3586-3595.
47. Mondragon L, Orzaez M, Sanclimens G, et al. Modulation of cellular apoptosis with apoptotic protease-activating factor 1 (Apaf-1) inhibitors. J Med Chem. 2008;51:521-529.
48. Takatani T, Takahashi K, Uozumi Y, et al. Taurine prevents the ischemia-induced apoptosis in cultured neonatal rat cardiomyocytes through Akt/caspase-9 pathway. Biochem Biophys Res Commun. 2004; 316:484-489.